GX-E2

· Genexine, Inc.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for GX-E2, covering 2015-01-29 to 2017-10-16. Get the full timeline:

Most recent: Clinical Trial Update: Study to Evaluate the Efficacy and Safety of GX-E2 in the Anemic Patients Diagnosed With Chronic Kidney Disease (CKD) [Phase 2]

See pricing